Hot off the presses; see the attachments for the accrual screen based on my latest anomaly article: http://hema.zacks.com/2011/11/lemons-or-lemondade/
Enjoy!
Hot off the presses; see the attachments for the accrual screen based on my latest anomaly article: http://hema.zacks.com/2011/11/lemons-or-lemondade/
Enjoy!
If I were you, I would check the results over a longer period. In the 1/08 to current, generates a +6% annually.
However, when I run a monthly rebalance from 12/17/99 to present, the return is around NEGATIVE 16.9%
per annum. Note that I did not use the attached screen which omitted the Zacks rank <=3
and bottom 10 (vs 10% in screen above) mentioned in the article. Also, I set the securities
type to exclude ADR and not to = COM. This is because the securities type = COM introduces a survivor
bias into the output since it is only picking stocks that CURRENTLY meet that criteria -- it does not
look at what the descriptor should have been historically. I found this out the hard way and had Kevin
Matras confirm it last year. Also, only looked at top 2000 mkt cap (not 3000) and avg $ volume traded of $2MM or higher.